Current Status of Allogeneic Hematopoietic Cell Transplantation for MDS

E-ISSN： 1873-4286|18|22|3215-3221

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.22, 2012-07, pp. : 3215-3221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation

By Servais Sophie Beguin Yves Baron Frédéric

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 173-192

Informa Healthcare

Access to resources Recommend Favorite

Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 69-76

Bentham Science Publishers

Access to resources Recommend Favorite

Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 363-365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimizing Outcomes Following Allogeneic Hematopoietic Progenitor Cell Transplantation in AML: The Role of Hypomethylating Agents

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 661-669

Bentham Science Publishers

Access to resources Recommend Favorite

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

By McDonald George B

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1709-1724

Informa Healthcare

Access to resources Recommend Favorite